كاليسيفاكس لقاح فيروس الكاليسي المعطل المخصص للقطط
Calicivax is an inactivated (killed virus) vaccine containing feline calicivirus (FCV) grown on an established cell line, formulated with a specialized adjuvant. Indicated for the vaccination of healthy cats 8 to 10 weeks of age or older as an aid in prevention of feline calicivirus infection and associated upper respiratory disease and oral ulceration.
Dosage Form
Injection
Product Type
Biological
Manufacturer
Package
Cartons of 25 x 1-dose vials (1 mL each)
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Cat | 1 mL administered subcutaneously | Subcutaneous (SC) | Primary vaccination consists of two 1 mL doses 3 to 4 weeks apart; revaccinate annually |
No withdrawal information available.
Vaccination of healthy cats 8 to 10 weeks of age or older as an aid in the prevention of disease caused by feline calicivirus.
Do not vaccinate clinically diseased or immunocompromised cats.
Contains gentamicin and thimerosal as preservatives. In case of anaphylactoid reaction, administer epinephrine.
Mild temporary pain or small transient nodule at the injection site.
Calicivax Feline Calicivirus Vaccine Prescribing Information
LeafletNo diseases linked.
No data available
Information has not been added yet.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.